Insider · CIK 0001111318

OCONNELL MAUREEN

Reports to the SEC for 7 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001111318

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	ACTGACACIA RESEARCH CORPS Sale	Director	SSale	−12.5K sh	$4.57	−$57K	254,655
2026-09-02	ACTGACACIA RESEARCH CORPS Sale	Director	SSale	−20.5K sh	$4.63	−$95.1K	267,121
2026-08-19	ACTGACACIA RESEARCH CORPS Sale	Director	SSale	−10K sh	$4.60	−$46K	287,655
2026-06-26	TEXTEREX CORPA Award	Director	AAward	+1,880 sh	$71.81	+$135K	18,235
2026-06-23	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+25.1K sh	—	—	297,655
2026-03-05	TEXTEREX CORPA Award	Director	AAward	+794 sh	$66.19	+$52.6K	16,351
2026-02-02	REVGREV Group, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−13.4K sh	—	—	2,105
2026-02-02	REVGREV Group, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,105 sh	—	—	0
2026-02-02	TEXTEREX CORPA Award	Director	AAward	+13.2K sh	—	—	13,177
2026-02-02	TEXTEREX CORPA Award	Director	AAward	+2,380 sh	—	—	15,557
2025-12-03	REVGREV Group, Inc.A Award	Director	AAward	+2,105 sh	—	—	15,539
2025-05-30	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+32.2K sh	—	—	272,603
2024-12-05	REVGREV Group, Inc.A Award	Director	AAward	+3,611 sh	—	—	13,434
2024-06-07	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+23.1K sh	—	—	240,431
2023-12-08	REVGREV Group, Inc.A Award	Director	AAward	+7,084 sh	—	—	9,823
2023-08-25	REVGREV Group, Inc.A Award	Director	AAward	+2,739 sh	—	—	2,739
2023-05-26	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+30.5K sh	—	—	217,310
2022-05-09	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+26.2K sh	—	—	186,776
2021-05-10	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+21.7K sh	—	—	160,575
2020-09-08	ACTGACACIA RESEARCH CORPP Purchase	Director	PPurchase	+13.5K sh	$3.77	+$50.8K	138,914
2020-09-04	ACTGACACIA RESEARCH CORPP Purchase	Director	PPurchase	+11.5K sh	$3.78	+$43.6K	125,444
2020-07-22	HHSHARTE HANKS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,557 sh	—	—	29,971
2020-07-22	HHSHARTE HANKS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,557 sh	—	—	0
2020-06-02	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+48K sh	—	—	113,914
2020-03-21	HHSHARTE HANKS INCM Exercise/Conversion	Director	MExercise/Conversion	+23.1K sh	—	—	25,414
2020-03-21	HHSHARTE HANKS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−23.1K sh	—	—	0
2019-07-30	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+43.5K sh	—	—	65,914
2019-05-08	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+22.4K sh	—	—	22,436
2019-03-21	HHSHARTE HANKS INCA Award	Director	AAward	+23.1K sh	—	—	29,971
2018-07-27	HHSHARTE HANKS INCA Award	Director	AAward	+6,835 sh	—	—	6,835
2018-02-13	Sucampo Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,130 sh	$18.00	−$92.3K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$12.81	−$384K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	$9.38	−$188K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	$11.20	−$224K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	$1.77	−$35.4K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$7.70	−$77K	0
2017-09-25	SCHLSCHOLASTIC CORPF Tax Payment	EVP, CAO & CFO	FTax Payment	−800 sh	$36.28	−$29K	31,121
2017-09-21	SCHLSCHOLASTIC CORPF Tax Payment	EVP, CAO & CFO	FTax Payment	−622 sh	$35.17	−$21.9K	31,921
2017-09-20	SCHLSCHOLASTIC CORPF Tax Payment	EVP, CAO & CFO	FTax Payment	−692 sh	$38.61	−$26.7K	32,543
2017-09-19	SCHLSCHOLASTIC CORPA Award	EVP, CAO & CFO	AAward	+5,440 sh	$38.60	+$210K	33,235
2017-09-19	SCHLSCHOLASTIC CORP · Employee stock option (right to buy)A Award	EVP, CAO & CFO	AAward	+46.9K sh	—	—	46,936
2017-09-18	SCHLSCHOLASTIC CORPF Tax Payment	EVP, CAO & CFO	FTax Payment	−898 sh	$39.04	−$35.1K	27,795
2017-09-05	SCHLSCHOLASTIC CORPM Exercise/Conversion	EVP, CAO & CFO	MExercise/Conversion	+5,028 sh	$39.34	+$198K	31,168
2017-09-05	SCHLSCHOLASTIC CORPF Tax Payment	EVP, CAO & CFO	FTax Payment	−2,475 sh	$39.34	−$97.4K	28,693
2017-09-05	SCHLSCHOLASTIC CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, CAO & CFO	MExercise/Conversion	−5,028 sh	$23.79	−$120K	0
2017-09-01	SCHLSCHOLASTIC CORP · Restricted Stock UnitsA Award	EVP, CAO & CFO	AAward	+4,954 sh	$28.76	+$142K	4,954
2017-08-03	SCHLSCHOLASTIC CORPF Tax Payment	EVP, CAO & CFO	FTax Payment	−1,725 sh	$40.64	−$70.1K	26,140
2017-06-01	Sucampo Pharmaceuticals, Inc.A Award	Director	AAward	+5,130 sh	—	—	14,930
2017-06-01	Sucampo Pharmaceuticals, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	100,000
2017-01-04	SCHLSCHOLASTIC CORPS Sale	EVP, CAO & CFO	SSale	−8,264 sh	$47.45	−$392K	27,865

Recent filings

Accepted (ET)
Sep 44
OCONNELL MAUREEN0001111318-26-000012
SEC(opens sec.gov)
Aug 204
OCONNELL MAUREEN0001111318-26-000009
SEC(opens sec.gov)
Jun 304
OCONNELL MAUREEN0001111318-26-000005
SEC(opens sec.gov)
Jun 254
OCONNELL MAUREEN0001111318-26-000003
SEC(opens sec.gov)
Mar 94
OCONNELL MAUREEN0000097216-26-000043
SEC(opens sec.gov)
Feb 44
OCONNELL MAUREEN0000097216-26-000022
SEC(opens sec.gov)
Feb 24
OCONNELL MAUREEN0000950103-26-001466
SEC(opens sec.gov)
Dec 54
OCONNELL MAUREEN0000950103-25-015837
SEC(opens sec.gov)
Jun 34
OCONNELL MAUREEN0001111318-25-000006
SEC(opens sec.gov)
Dec 104
OCONNELL MAUREEN0000950103-24-017518
SEC(opens sec.gov)
Jun 114
OCONNELL MAUREEN0001111318-24-000003
SEC(opens sec.gov)
Dec 124
OCONNELL MAUREEN0000950103-23-017431
SEC(opens sec.gov)
Aug 294
OCONNELL MAUREEN0000950103-23-012904
SEC(opens sec.gov)
May 314
OCONNELL MAUREEN0001111318-23-000002
SEC(opens sec.gov)
May 114
OCONNELL MAUREEN0001111318-22-000004
SEC(opens sec.gov)
May 124
OCONNELL MAUREEN0001683168-21-001908
SEC(opens sec.gov)
Sep 84
OCONNELL MAUREEN0001683168-20-003064
SEC(opens sec.gov)

Companies

Address

777 THIRD AVENUE SUITE 2602

NEW YORK, NY, 10017